Fusion Antibodies Plc

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Fusion Antibodies Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 81.82% vs -62.07% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 22.73% vs 15.38% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.00",
          "val2": "1.10",
          "chgp": "81.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.60",
          "val2": "-2.10",
          "chgp": "23.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.70",
          "val2": "-2.20",
          "chgp": "22.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-878.40%",
          "val2": "-2,004.40%",
          "chgp": "112.60%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

2.00

1.10

81.82%

Operating Profit (PBDIT) excl Other Income

-1.60

-2.10

23.81%

Interest

0.00

0.00

Exceptional Items

0.00

0.00

Consolidate Net Profit

-1.70

-2.20

22.73%

Operating Profit Margin (Excl OI)

-878.40%

-2,004.40%

112.60%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 81.82% vs -62.07% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 22.73% vs 15.38% in Mar 2024

All Annual Results